Systemic Therapies for the Management of Non–Clear Cell Renal Cell Carcinoma: What Works, What Doesn’t, and What the Future Holds-Reference-Cited by-同舟云学术

Systemic Therapies for the Management of Non–Clear Cell Renal Cell Carcinoma: What Works, What Doesn’t, and What the Future Holds

Published:2021-04 Issue:2 Volume:19 Page:103-116
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Zoumpourlis Panagiotis,Genovese Giannicola,Tannir Nizar M.,Msaouel Pavlos^ORCID

Funder

Kidney Cancer Association

U.S. Department of Defense

National Cancer Institute

Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference130 articles.

1. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours;Moch;Eur Urol,2016

2. Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: a review of the evidence using second-generation p-values;Adashek;Cancer Treat Res Commun,2020

3. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC);Rini;J Immunother Cancer,2019

4. Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma;Msaouel;Clin Genitourin Cancer,2019

5. Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d’Etudes des Tumeurs Uro-genitales) study;Oudard;J Urol,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma;The Journal of Pathology;2024-08-02

2. Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients;European Urology Oncology;2024-07

3. Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions;Current Oncology Reports;2024-06-07

4. The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience;Journal of Kidney Cancer and VHL;2024-03-02

5. Development and validation of a prognostic model predicting the prognosis of surgically treated non-clear cell renal cell carcinoma patients with tumor thrombus;2024-02-27